Lawdragon Names Seven Seeger Weiss Partners to 2027 500 Leading Litigators in America Guide

Lawdragon has recognized seven Seeger Weiss partners—Christopher Seeger, Stephen Weiss, Parvin Aminolroaya, Ben Barnett, David Buchanan, Shauna Itri, and Jennifer Scullion—in its 2027 Lawdragon 500 Leading Litigators in America guide.

September 15, 2026

Lawdragon has recognized seven Seeger Weiss partners—Christopher Seeger, Stephen Weiss, Parvin Aminolroaya, Ben Barnett, David Buchanan, Shauna Itri, and Jennifer Scullion—in its 2027 Lawdragon 500 Leading Litigators in America guide.

The guide highlights attorneys whose courtroom, investigative, and regulatory work has produced real impacts for the clients they represent, with many honorees credited with influencing entire industries or the way laws in their field are enforced.

Honorees are drawn from firms nationwide and recognized across practice areas including commercial litigation, product liability, mass torts, securities, class actions, antitrust, and energy law, among others.

The recognized Seeger Weiss attorneys have held leadership roles in some of the country’s largest mass tort and class action litigations, including the 3M Combat Arms Earplug Products Liability Litigation, the Philips Recalled CPAP, Bi-Level PAP, and Mechanical Ventilator Products Litigation, and the National Prescription Opiate Litigation. They also hold key roles in ongoing cases in the Depo-Provera Products Liability Litigation, the GLP-1 RAs Products Liability Litigation, and Change Healthcare, Inc., Customer Data Security Breach Litigation. Their work has helped drive multibillion-dollar recoveries for injured plaintiffs and consumers nationwide.

Lawdragon’s selection is a time-honored methodology performed through independent journalistic research and submissions. Decisions are carefully made based on factors including research of top verdicts and settlements, peer recognition, and interviews with lawyers nationwide.

No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

The selection methodology can be found here.

Related News

October 25, 2026
Seeger Weiss Partner Christopher A. Seeger Receives Inaugural Monroe E. Price Award from the Benjamin N. Cardozo School of Law

Seeger Weiss Partner Christopher Seeger received the inaugural Monroe E. Price Award from the Benjamin N. Cardozo School of Law, his alma mater, at the school’s 50th Anniversary Gala at the Hall des Lumières in New York City on October 22, 2026. The award is named for Monroe Price, who served as Dean of Cardozo […]

Read More
October 23, 2026
Seeger Weiss’s Christopher A. Seeger Appointed Co-Lead Counsel in In re: Dupixent (Dupilumab) Products Liability Litigation

Seeger Weiss LLP is pleased to announce that Partner Christopher A. Seeger has been appointed Co-Lead Counsel in In re: Dupixent (Dupilumab) Products Liability Litigation, MDL No. 3180, pending in the U.S. District Court for the District of New Jersey. The litigation involves claims that Dupixent, an injectable biologic prescribed to treat inflammatory conditions including […]

Read More
September 14, 2026
Seeger Weiss Recognized as a Finalist for Litigation Department of the Year, Products Liability/Mass Torts Category at the 2026 New Jersey Legal Awards

Seeger Weiss has been recognized as a finalist for Litigation Department of the Year, Products Liability/Mass Torts at the New Jersey Law Journal’s 2026 New Jersey Legal Awards. This recognition reflects a year of leadership appointments and firm growth across the department’s most significant matters. In March 2025, founding partner Christopher A. Seeger was appointed […]

Read More
↑